Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries
Global trials are geographically and developmentally unbalanced, with incomplete public availability of trial results, and future research should strengthen international collaboration, optimize trial phase distribution, support novel agent development, and promote timely and complete public disclosure of trial results...
Li-Chuan Zhang, Qi Tian, Ya-Lin Tang et al.
· Frontiers in Pharmacology · 0 citations